Concentra Group Holdings Parent Inc (CON) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Concentra Group Holdings Parent Inc   (NYSE: CON)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare


Concentra Group Holdings Parent Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Concentra Group Holdings Parent Inc 's ROA in the second quarter of 2026?
Concentra Group Holdings Parent Inc achieved a return on average assets (ROA) of 7.09 % in its second quarter of 2026 a new company high.

ROA has improved compared to 6.45% in the first quarter of 2026, due to net income growth.

However, within the Healthcare sector 126 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 968, from total ROA ranking in the first quarter of 2026 at 1179.

What is ROA?



Return On Assets (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 5.94 % 5.88 % 12.77 % 14.63 % 20.24 %
Y / Y Net Income Change 45.69 % 28.66 % 58.73 % 8.88 % -12.94 %
Net Income (TTM) in million 206 184 173 159 155
Return On Assets (TTM) 7.09 % 6.45 % 6.13 % 5.83 % 5.87 %
CON's Total Ranking # 968 # 1179 # 1052 # 1033 # 969
Total Assets (TTM) in million 3,010 2,890 2,858 2,844 2,842
Seq. Total Assets Change 4.17 % 1.1 % 0.51 % 0.08 % 4.12 %
Seq. Net Income Change 28.7 % 44.49 % -27.36 % 7.85 % 13.66 %



Return On Assets Company Ranking
Within: No.
Industry # 14
Sector # 127
Overall # 878

Return On Assets Statistics
High Average Low
7.09 %
6.41 %
5.83 %
(Jun 30 2026)   (Sep 30 2025)





Financial Statements
Concentra Group Holdings Parent Inc 's Assets $ 3,010 million CON's Balance sheet
Concentra Group Holdings Parent Inc 's Income $ 67 million Quarterly CON's Income Statement
CON's Income by Division See CON's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025
(Dec 31 2024)
FY 2024

FY

FY

FY
Y / Y Total Assets Change 13.38 % - - - -
Total Assets in million 2,858 2,521 0 0 0
Y / Y Net Income Change 0.55 % - - - -
Net Income in million 173 172 0 0 0
Annual Return On Assets 6.05 % 6.82 % - - -




Comment on CON's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA deteriorated to 6.05 %, despite annual net income growth of 0.55 % to $172.85 million, from $171.90 million a year ago, as CON's assets increase to $2,858.39 million, by 0.55 %.


More Return On Assets Ratios
CON's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CON's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CON's Competitors
Subscribers only: Roa for Concentra Group Holdings Parent Inc 's Suppliers
Subscribers only: Return On Assets for CON's Customers

You may also want to know
CON's Roi CON's Inventory Turnover Ratio CON's Growth Rates CON's Dividend Comparisons
CON's Profitability Ratios CON's Asset Turnover Ratio CON's Dividend Growth
CON's Roe CON's Valuation Ratios CON's Financial Strength Ratios CON's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Electromed Inc   19.39 %
United Therapeutics Corporation  17.98 %
Resmed Inc   17.80 %
Krystal Biotech Inc   17.65 %
Chemed Corporation  17.52 %
Zoetis Inc   17.19 %
Vertex Pharmaceuticals Inc  16.88 %
Halozyme Therapeutics Inc   16.55 %
Alnylam Pharmaceuticals Inc   15.76 %
Intuitive Surgical Inc   15.63 %
Healthcare Services Group Inc   15.21 %
Inspire Medical Systems inc   15.21 %
Dexcom Inc   14.87 %
Neurocrine Biosciences Inc   14.73 %
Entera Bio Ltd   14.60 %
Standard Biotools Inc   14.31 %
Arcutis Biotherapeutics Inc   14.23 %
Harmony Biosciences Holdings inc   14.15 %
Biolife Solutions Inc   14.09 %
Aveanna Healthcare Holdings Inc   13.82 %
West Pharmaceutical Services Inc   13.64 %
Medinotec Inc   13.38 %
Puma Biotechnology Inc   13.28 %
Sbc Medical Group Holdings Incorporated  13.26 %
Alpha Pro Tech Ltd   13.17 %
Illumina Inc   12.68 %
Spero Therapeutics Inc   12.57 %
Transmedics Group Inc   12.50 %
Eton Pharmaceuticals Inc   12.37 %
Nephros Inc   12.30 %


Date modified: 2026-09-08T17:13:09+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.